104 related articles for article (PubMed ID: 6848299)
21. Ventilatory effects of atenolol and bevantolol in asthma.
Lammers JW; Folgering HT; van Herwaarden CL
Clin Pharmacol Ther; 1985 Oct; 38(4):428-33. PubMed ID: 4042527
[TBL] [Abstract][Full Text] [Related]
22. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
[TBL] [Abstract][Full Text] [Related]
23. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
[TBL] [Abstract][Full Text] [Related]
24. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Kerr D; MacDonald IA; Heller SR; Tattersall RB
Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
[TBL] [Abstract][Full Text] [Related]
25. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
26. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
27. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
[TBL] [Abstract][Full Text] [Related]
29. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
[TBL] [Abstract][Full Text] [Related]
30. Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.
Gribbin HR; Mackay AD; Baldwin CJ; Tattersfield AE
Br J Clin Pharmacol; 1981 Jul; 12(1):61-5. PubMed ID: 6264936
[TBL] [Abstract][Full Text] [Related]
31. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
[TBL] [Abstract][Full Text] [Related]
32. The H1-antagonist mequitazine: studies on performance and visual function.
Nicholson AN; Stone BM
Eur J Clin Pharmacol; 1983; 25(4):563-6. PubMed ID: 6418550
[TBL] [Abstract][Full Text] [Related]
33. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
[TBL] [Abstract][Full Text] [Related]
35. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
McGibney D; Singleton W; Silke B; Taylor SH
Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
[TBL] [Abstract][Full Text] [Related]
36. Bioequivalence of two atenolol formulations in healthy volunteers. Evaluation and prediction of effect kinetics at beta-adrenoceptors in vivo by means of a radioreceptor assay.
Sitzler G; Heibel B; Lücker PW; Palm D
Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):129-37. PubMed ID: 1677061
[TBL] [Abstract][Full Text] [Related]
37. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
Teeuw AH; Leenen FH; Geyskes GG; Boer P
Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
[TBL] [Abstract][Full Text] [Related]
38. Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.
Deacon SP; Barnett D
Br Med J; 1976 Jul; 2(6030):272-3. PubMed ID: 8184
[TBL] [Abstract][Full Text] [Related]
39. Effects of i.v. lignocaine on psychological performance and subjective state in healthy volunteers.
Armstrong PJ; Morrison LM; Noble D; Sinclair WA; Tiplady B; Wildsmith JA
Br J Anaesth; 1991 Nov; 67(5):532-8. PubMed ID: 1751265
[TBL] [Abstract][Full Text] [Related]
40. Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: a placebo-controlled, double-blind comparative study.
Gatti G; Barzaghi N; Dominijanni R; Cordaro C; Perucca E
Drugs Exp Clin Res; 1993; 19(1):33-9. PubMed ID: 8223138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
